Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Implantable Microdevice for Evaluation of Drug Response in Patients with Localized Bladder Cancer Undergoing Radical Cystectomy

Trial Status: active

This early phase I trial tests the safety and feasibility of an implantable microdevice for the evaluation of drug response in patients with bladder cancer that has not spread to other parts of the body (localized) and who are undergoing surgery to remove all of the bladder (radical cystectomy). A microdevice is surgically placed inside of a tumor and then releases microdoses of specific drugs or drug combinations as a possible tool to evaluate the effectiveness of several cancer drugs against bladder cancer.